MIRA Pharmaceuticals announces 2024 annual meeting results; all proposals approved

MIRA PHARMACEUTICALS, INC.

All five director nominees elected; each received over 6.6M votes (70.4% of votes cast).
Ratification of Cherry Bekaert LLP as auditor for FY2024 approved with 9.4M votes for (99.9%).
Amendment to 2022 Omnibus Incentive Plan to increase available shares approved with 6.57M votes for (84.6% of votes cast).
Adjournment proposal withdrawn after sufficient votes obtained for proposals 1 and 3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.